avian, birds, worldwide, influenza

Nanotherapeutics files NanoDTPA IND for treatment of radiation exposure
Nanotherapeutics, Inc., announced that it has filed an Investigational New Drug (IND) Application with the Food and Drug Administration (FDA) for NanoDTPA™ an orally administered capsule that is a less invasive treatment alternative to the FDA approved injectable Zn-DTPA (diethylenetriamine pentacetic acid). DTPA is used to remove radioactive

Aethlon Medical receives approval for Chronic HCV Infection treatment
Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that the Medanta Independent Ethics Committee (MIEC) at Medanta, The Medicity Institute (Medicity) has approved a treatment program entitled "Use of the Aethlon Hemopurifier in Treating Chronic HCV Infection in

Aethlon Medical signs agreement with GVK BIO to expand Hemopurifier technology in India
Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, today announced that it has entered into an agreement with GVK Biosciences to expand the opportunity for Aethlon to commercialize its Hemopurifier treatment technology at three to five new clinical centers in

Intercell reports significant increase in second quarter revenue
Today, Intercell AG announced its financial results for Q2 and H1 2010.IXIARO/JESPECT sales increased significantly from EUR 2.4m in Q2 2009 to EUR 5.2m in Q2 2010 Continued focus on growing marketing and sales of product in traveler and military markets

Sinovac Biotech second-quarter 2010 sales increase 131% to $10.3 million
Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today its unaudited financial results for the three-month and six-month periods ended June 30, 2010.

TLV, Emergent BioSolutions form joint venture to develop broad spectrum pandemic flu vaccine
Temasek Life Science Ventures Pte Ltd and Emergent BioSolutions Inc. today announced their agreement to form EPIC BIO Pte Ltd, a joint venture to develop, manufacture, and commercialize a multivalent, cross-protective human vaccine to protect against influenza caused by a broad range of circulating H5 influenza strains.

Medicago USA awarded $21M to develop vaccine facility in Research Triangle Park
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects

NanoViricides presents study results of nanoviricides anti-Ebola agents
NanoViricides, Inc. reports that the results of the evaluation of several of its nanoviricides anti-Ebola agents were presented July 17th at the Annual Meeting of the American Society for Virology, July 17-21, at Montana State University, Bozeman, MT. Dr. Corinne Scully delivered the presentation, which was entitled "Polymeric

BioRadar develops TransFMDV for Foot and Mouth Disease
BioRadar UK Ltd. predicted one year ago the current severe Foot and Mouth Disease (FMD) outbreaks after recording an increase of the Replikin Count (ref. 1) of the FMD Virus (FMDV) to its highest level in 52 years. Based on these findings, a new synthetic Replikins Trans-Strain FMD

Aethlon Medical files provisional patent on behalf of ESI for exosome detection assay
Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has filed a provisional patent on behalf of its wholly owned subsidiary Exosome Sciences, Inc. (ESI), relating to the development of an assay that will allow researchers to

Latest Searches: white, fasr typepad com p12 html, human, youtoupxxx, fasr typepad com p13 html, cancer, sleep, kbadmintonclub, severe, birth, WJGpTVAOKeQyY, hydr ull sho, pharmacy, modular math washington e, medullary, federal. Top Searches...

Common typos for 'Bird-Blu' : birdbou, bir-d bul, bird bku, birrd nlu, bir blu, bid blu, bidr blu, bird b-lu, b ird blu, birrd- blu, birdb l, bird bul, b-i rd blu, ird bou, bi rd blu, birdblu, birrd blu, bifd blu, brid blu, b-ird blu, bi-rd blu, bir dlbu, ibrd blu, brdblu, birrd bllu, biirrd blu.
More 'Bird-Blu' Typos...